Published in partnership with High Level Data, a D.C. based cannabis data publisher. This monthly data feature will be available to Outlaw Report supporters two weeks early. Sign up today.
Washington, D.C.’s medical cannabis market is witnessing a significant shift, with vape cartridges rapidly gaining traction and claiming a dominant position. In March 2025, vape carts accounted for 16% of total cannabis sales in the District, marking a substantial 60% increase compared to the 2024 average. Since January 2024, the category experienced an average monthly growth of 23%, outpacing all other product types. While tincture volume growth was slightly higher, vape cart sales have soared by 689% since March 2024, with prices remaining remarkably stable around an average of $41.09 over the past 15 months, indicating strong demand.
This growth is accompanied by an expansion in product variety and quality. By early 2025, D.C. boasted 47 unique vape strains tested, with THC content averaging 73.6% and terpene content showcasing significant diversity. While D.C.’s vape cart market share lagged behind Maryland and national averages in late 2024, the gap is quickly narrowing. Driven by younger consumers and new dispensary openings, vape carts are transitioning from a secondary offering to a key revenue driver and a central force in the D.C. cannabis market’s momentum.
